Anest. intenziv. Med. 2025;36(2):107 | DOI: 10.36290/aim.2025.025

Stanovisko výboru ČSARIM Zachování dostupnosti sukcinylcholinu v klinické praxiReports from professional societies

Balík M., Beneš J., Bláha J., Černá Pařízková R., Černý V., Duška F., Dostál P., Gabrhelík T., Mach D., Michálek P., Stern M., Ševčík P., Štourač P., Truhlář A., Vymazal T.

Accepted: June 18, 2025; Published: June 27, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Balík M, Beneš J, Bláha J, Černá Pařízková R, Černý V, Duška F, et al.. Stanovisko výboru ČSARIM Zachování dostupnosti sukcinylcholinu v klinické praxi. Anest. intenziv. Med. 2025;36(2):107. doi: 10.36290/aim.2025.025.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • PDF will be unlocked 27.6.2026

    References

    1. . American Society of Anesthesiologists (ASA) Guidelines for Neuromuscular Blockade, 2022.
    2. . Difficult Airway Society (DAS) Guidelines, 2021.
    3. . Deutsche Gesellschaft für Anästhesiologie und Intensivmedizin (DGAI) RSI Stellungnahme, 2020.
    4. . NICE Clinical Guidelines: Rapid Sequence Induction, 2023.
    5. . Naguib M, et al. Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade: Meta-analysis. Anesthesiology. 2017;126(3):482-495.
    6. . Martyn JA, et al. Succinylcholine-induced hyperkalemia in acquired pathologic states: Etiologic factors and molecular mechanisms. Anesthesiology. 2006;104(1):158-169. Go to original source... Go to PubMed...

    Return to the content


    Anesteziologie a intenzivní medicína

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.